This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Alan Geoffrey Ironmonger: Innovator in Pharmaceutical Processes
Introduction
Alan Geoffrey Ironmonger is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel processes for preparing complex compounds. His work has implications for the creation of new therapeutic agents.
Latest Patents
Ironmonger holds a patent for "Processes for preparing 2-(6-(1H-indol-4-yl)-1H-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)oxazole." This invention provides novel processes for preparing compounds of formula (IV) and salts thereof, as well as novel intermediates, and a novel salt and polymorph thereof. He has 1 patent to his name, showcasing his innovative approach to chemical synthesis.
Career Highlights
Ironmonger is associated with GlaxoSmithKline Intellectual Property Development Limited, where he applies his expertise in pharmaceutical development. His role involves not only inventing new processes but also ensuring that these innovations can be effectively utilized in drug development.
Collaborations
He has collaborated with notable colleagues such as Robert Nicholas Bream and John David Hayler, contributing to a dynamic team focused on advancing pharmaceutical technologies.
Conclusion
Alan Geoffrey Ironmonger exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through his patent work and collaborations highlight the importance of research and development in creating new therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile